A single patient case published in Cureus looks at semaglutide for low blood sugar after meals that hadn't responded to other approaches.
Recap by typeshit. Full story at Cureus.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
Bikman says the added glucagon receptor push raises energy use and liver fat burning, and points to 24.2% weight loss on 12 mg in phase 2.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
A report says an Eli Lilly drug helped protect muscle mass when combined with Novo's Wegovy, addressing a common worry about lean mass loss.
Polskie Radio reports the FDA has added a new warning to the labels of weight loss drugs, Wegovy among them. Details are at the link.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Loading…